The DOI matches its Crossref record; 16 of the 16 references it cites were found in a registry or an index.
Neuroendocrine Differentiation in Hormone Refractory Prostate Cancer Following Androgen Deprivation Therapy
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Leuprolide versus Diethylstilbestrol for Metastatic Prostate Cancer
The Leuprolide Study Group (1984) · New England Journal of Medicine · doi:10.1056/nejm198411153112004 · Cited by 622
Di Sant'Agnese, P. A. (1992) · Cancer · doi:10.1002/1097-0142(19920701)70:1+<254::aid-cncr2820701312>3.0.co;2-e · Cited by 387
Neuroendocrine differentiation in prostatic carcinoma
Abrahamsson, P.-A. (1999) · The Prostate · doi:10.1002/(sici)1097-0045(19990501)39:2<135::aid-pros9>3.0.co;2-s · Cited by 370
Bonkhoff, H., Wernert, N., Dhom, G., & Remberger, K. (1991) · The Prostate · doi:10.1002/pros.2990190202 · Cited by 198
Elevated Plasma Chromogranin-A Concentrations in Prostatic Carcinoma
Kadmon, D., Thompson, T. C., Lynch, G. R., & Scardino, P. T. (1991) · Journal of Urology · doi:10.1016/s0022-5347(17)37793-5 · Cited by 165
Bonkhoff, H., Stein, U., & REMBERGER, K. (1993) · Archiv für Pathologische Anatomie und Physiologie und für Klinische Medicin · doi:10.1007/bf01606893 · Cited by 150
Neuroendocrine Differentiation in Prostatic Carcinoma During Hormonal Treatment
Jiborn, T., Bjartell, A., & Abrahamsson, P.-A. (1998) · Urology · doi:10.1016/s0090-4295(97)00684-5 · Cited by 149
Do neuroendocrine cells in human prostate cancer express androgen receptor?
Krijnen, J. L. M., Janssen, P. J. A., de Winter, J. A. R., et al. (1993) · Histochemistry and Cell Biology · doi:10.1007/bf00268938 · Cited by 143
Harper, M., Glynne-Jones, E., Goddard, L., Thurston, V., & Griffiths, K. (1996) · British Journal of Cancer · doi:10.1038/bjc.1996.456 · Cited by 140
Krijnen, J. L. M., Bogdanowicz, J. F. A. T., Seldenrijk, C. A., Mulder, P. G. H., & van der Kwast, T. (1997) · The Journal of Urology · doi:10.1097/00005392-199707000-00054 · Cited by 108
Cited by
Molecular Characterization of Neuroendocrine Prostate Cancer and Identification of New Drug Targets
Beltran, H., Rickman, D. S., Park, K., Chae, S. S., Sboner, A., MacDonald, T. Y., Wang, Y., Sheikh, K. L., Terry, S., Tagawa, S. T., et al. (2011) · Cancer Discovery · doi:10.1158/2159-8290.cd-11-0130 · Cited by 999
Proposed Morphologic Classification of Prostate Cancer With Neuroendocrine Differentiation
Epstein, J. I., Amin, M. B., Beltran, H., Lotan, T. L., Mosquera, J.-M., Reuter, V. E., Robinson, B. D., Troncoso, P., & Rubin, M. A. (2014) · American Journal of Surgical Pathology · doi:10.1097/pas.0000000000000208 · Cited by 569
Cellular plasticity and the neuroendocrine phenotype in prostate cancer
Davies, A. H., Beltran, H., & Zoubeidi, A. (2018) · Nature Reviews Urology · doi:10.1038/nrurol.2018.22 · Cited by 431
Zou, M., Toivanen, R., Mitrofanova, A., Floch, N., Hayati, S., Sun, Y., Le Magnen, C., Chester, D., Mostaghel, E. A., Califano, A., et al. (2017) · Cancer Discovery · doi:10.1158/2159-8290.cd-16-1174 · Cited by 386
Jin, R. J., Lho, Y., Connelly, L., Wang, Y., Yu, X., Saint Jean, L., Case, T. C., Ellwood-Yen, K., Sawyers, C. L., Bhowmick, N. A., et al. (2008) · Cancer Research · doi:10.1158/0008-5472.can-08-0107 · Cited by 182
Metadata
- Authors
- Hirano, D., Okada, Y., Minei, S., Takimoto, Y., & Nemoto, N.
- Venue
- European Urology
- Publisher
- Elsevier BV
- Published
- 2004-05
- Volume
- 45
- Issue
- 5
- Pages
- 586-592
- ISSN
- 0302-2838 (ISSN-L)
- OpenAlex
- W1975356306
- Cited by
- 303
- References
- 16
- FWCI
- 7.29
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Neuroendocrine Differentiation in Hormone Refractory Prostate Cancer Following Androgen Deprivation Therapy. https://app.cochat.ai/papers/10.1016/j.eururo.2003.11.032
- The paper
- Hirano, D., Okada, Y., Minei, S., Takimoto, Y., & Nemoto, N. (2004). Neuroendocrine Differentiation in Hormone Refractory Prostate Cancer Following Androgen Deprivation Therapy. European Urology. https://doi.org/10.1016/j.eururo.2003.11.032
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.